Recombinant Human Platelet-derived Growth Factor B(Lynch Regenerative Medicine)

N/A

Report date: 2024/10/10 20:00:04

Base Information

Drug NameRecombinant Human Platelet-derived Growth Factor B(Lynch Regenerative Medicine)
Drug Alias NamerhPDGF-BB
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionPlatelet-derived growth factor subunit B stimulants
TargetsPlatelet-derived growth factor subunit B
Therapy Area/IndicationsRectal Fistula
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLynch Regenerative Medicine LLC
China Registration ClassN/A

Develop Information

Active CompaniesLynch Regenerative Medicine LLC
Inactive CompaniesN/A
Active IndicationsRectal Fistula
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A